Variable | No of patients | Univariate P | Multivariate P | HR | 95% CI | |
Age | <70 ≥70 | n = 37 n = 15 | 0.04 | 0.03 | 3.4 | 1.2 - 10.2 |
Gender | M F | n = 34 n = 18 | 0.12 |
|
|
|
WBC (/μl) | <6500 ≥6500 | n = 33 n = 19 | 0.12 |
|
|
|
Neutrophil (/μl) | <5000 ≥5000 | n = 41 n = 11 | 0.38 |
|
|
|
Lymphcyte (/μl) | <1200 ≥1200 | n = 15 n = 37 | 0.92 |
|
|
|
NLR | <5 ≥5 | n = 48 n = 4 | 0.63 |
|
|
|
AST (IU/l) | <20 ≥20 | n = 30 n = 22 | 0.7 |
|
|
|
ALT (IU/l) | <30 ≥30 | n = 34 n = 18 | 0.62 |
|
|
|
T.Bil (mg/dl) | <0.8 ≥0.8 | n = 43 n = 9 | 0.38 |
|
|
|
T.P (g/dl) | <6.0 ≥6.0 | n = 6 n = 46 | 0.49 |
|
|
|
Alb (g/dl) | <3.5 ≥3.5 | n = 9 n = 43 | 0.78 |
|
|
|
CEA (ng/ml) | <5.0 ≥5.0 | n = 9 n = 43 | 0.15 |
|
|
|
CA19-9 (U/ml) | <60 ≥60 | n = 29 n = 23 | 0.89 |
|
|
|
CRP(mg/dl) | <1 ≥1 | n = 39 n = 13 | 0.81 |
|
|
|
GPS | <1 ≥1 | n = 36 n = 16 | 0.87 |
|
|
|
Tumor location | Colon Rectum | n = 43 n = 9 | 0.76 |
|
|
|
Pathology | Diff Non diff | n = 50 n = 2 | 0.31 |
|
|
|
Serosal invasion | Yes No | n = 17 n = 35 | 0.41 |
|
|
|
Vascular invasion | Yes No | n = 38 n = 14 | 0.51 |
|
|
|
Lymphatic invasion | Yes No | n = 20 n = 32 | 0.13 |
|
|
|
Lymph-node metastasis | Yes No | n = 35 n = 17 | 0.12 |
|
|
|
Hepatic metastasis | Yes No | n = 4 n = 48 | <0.01 | 0.06 | 2.9 | 1.0 - 9.1 |
Lung metastasis | Yes No | n = 3 n = 49 | 0.90 |
|
|
|
Peritoneal metastasis | Yes No | n = 3 n = 49 | 0.41 |
|
|
|
Chemotherapy | Yes No | n = 43 n = 9 | 0.01 | 0.09 | 3.0 | 0.1 - 1.1 |